smoldering multiple myeloma

Research shows new treatment could delay cancer progression in patients with high-risk smoldering multiple myeloma

Daratumumab, a monoclonal antibody drug, significantly reduces the risk of progression to active multiple myeloma and improves overall survival compared to active monitoring.

Multiple myeloma: Its evolution, treatment and the quest to catch it early

Dr. Joselle Cook discusses how multiple myeloma evolves, its treatment and research into screening methods.